Alan Wise (L) and Peter Trill (Duke Street Bio)

They sold their last biotech to Mer­ck. Now they're back with a PARP out­fit named af­ter a Lon­don street

In 2016, Pe­ter Trill and Alan Wise sold IOmet Phar­ma (an I/O out­fit as the name sug­gests) to Mer­ck for $400 mil­lion.

Now, some six …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.